Efficacy and Safety of Proposed Biosimilar Natalizumab (PB006) in Patients With Relapsing-Remitting Multiple Sclerosis: The Antelope Phase 3 Randomized Clinical Trial

por Hemmer, Bernhard, Wiendl, Heinz, Roth, Karsten, Wessels, Hendrik, Höfler, Josef, Hornuss, Cyrill, Liedert, Bernd, Selmaj, Krzysztof
Publicado 2023

Variability of linezolid concentrations after standard dosing in critically ill patients: a prospective observational study

por Zoller, Michael, Maier, Barbara, Hornuss, Cyrill, Neugebauer, Christina, Döbbeler, Gundula, Nagel, Dorothea, Holdt, Lesca Miriam, Bruegel, Mathias, Weig, Thomas, Grabein, Béatrice, Frey, Lorenz, Teupser, Daniel, Vogeser, Michael, Zander, Johannes
Publicado 2014